CHEManager International Pharma & Biotech

11.09.2020 • Topics • Strategy

Evolving an Entrepreneurial Ecosystem

We are in the midst of a start-up revolution. The growth of innovation-driven start-up activity is profound and global in scope, and it is a driving force of change even in mature industries such as the chemical and pharmaceutical sector.

13.09.2019 • Topics • Strategy

Injecting Growth and Innovation

09.09.2019 • Topics • Strategy

Sustainable Chemical Supply Chains

12.09.2016 • Topics • Technology

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.